[ad_1]
Synopsis
The pharma inventory with a market capitalisation of greater than Rs 1.97 lakh crore fell from its current 52-week excessive of Rs 966 recorded on 29 April 2022 to Rs 821.75 on 15 June 2022 – that interprets right into a draw back of over 15 per cent.
Solar Pharma, a part of the S&P BSE Sensex index, misplaced momentum after hitting a 52-week excessive in April 2022 and a contemporary brief buildup within the inventory means that the promoting strain may proceed within the close to time period.
The pharma inventory with a market capitalisation of greater than Rs 1.97 lakh crore fell from its current 52-week excessive of Rs 966 recorded on 29 April 2022 to Rs 821.75 on 15 June 2022 – that interprets right into a draw back of over 15 per
- FONT SIZE
AbcSmall
AbcMedium
AbcGiant
Why ?
-
Unique Financial Instances Tales, Editorials & Skilled opinion throughout 20+ sectors
-
Inventory evaluation. Market Analysis. Trade Developments on 4000+ Shares
-
Clear expertise with
Minimal Adverts -
Remark & Interact with ET Prime group -
Unique invitations to Digital Occasions with Trade Leaders -
A trusted group of Journalists & Analysts who can greatest filter sign from noise
[ad_2]
Source link